BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,605 | -20.5% | 251 | 0.0% | 0.00% | – |
| Q2 2023 | $15,863 | +40.5% | 251 | 0.0% | 0.00% | – |
| Q1 2023 | $11,292 | +2.7% | 251 | 0.0% | 0.00% | – |
| Q4 2022 | $10,996 | -35.3% | 251 | 0.0% | 0.00% | – |
| Q3 2022 | $17,000 | +30.8% | 251 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | -18.8% | 251 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | -99.3% | 251 | -99.0% | 0.00% | -100.0% |
| Q2 2019 | $2,237,000 | +47.2% | 24,100 | +46.1% | 0.01% | +16.7% |
| Q1 2018 | $1,520,000 | – | 16,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |